In the letter dated Aug. 8, ASL Strategic Value says several missteps in recent years have led to the downfall of CHS, including the company’s 2014 acquisition of Health Management Associates in Naples, Fla.
“It is time for the board to exercise its fiduciary duty to the shareholders and replace the current CEO,” states the letter from ASL.
After the letter was released, CHS shares climbed more than 11 percent in afternoon trading to $7.80 per share, according to Reuters.
More articles on healthcare finance:
CMS cancels cardiac bundles, scales back CJR model: 8 things to know
IRS revokes hospital’s tax-exempt status for failure to comply with ACA rule
Tenet board upheaval could lead to activist campaign
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
